Target intelligence / Profile preview

CDAN1-interacting nuclease 1 (CDIN1)

Target
CDIN1
Molecular classification
Enzyme (putative nuclease), Other (chromatin regulation complex component)
01

Overview

CDAN1-interacting nuclease 1 (CDIN1, also known as C15orf41) is an essential and ubiquitously expressed protein that interacts with Codanin-1 (CDAN1) to form a cytosolic complex. CDIN1 is predicted to act as a nuclease, involved in DNA repair and possibly in DNA replication through correction of replication errors. The CDAN1-CDIN1 complex also incorporates histone chaperones ASF1A and ASF1B, implicating a role in chromatin regulation. Mutations in CDIN1 are causative for congenital dyserythropoietic anemia type I (CDA-I), a rare hereditary disease characterized by defective erythropoiesis, anemia, and nuclear abnormalities in erythroblasts. The precise molecular function of human CDIN1 is still under investigation and no natural physiological nucleic acid substrates have been conclusively identified. CDIN1 is essential for viability, as knockout is embryonically lethal in animal models. There are no therapeutic agents that currently target CDIN1 directly.

Other names
C15orf41HH114MGC11326FLJ22851Protein HH114CDAN1-interacting nuclease 1protein C15orf41uncharacterized protein C15orf41CDIN1
02

Biological functions

DNA repair (proposed; correcting errors during DNA replication)Erythropoiesis (development of red blood cells)Chromatin regulation (indirect via protein complex formation)
03

Disease associations

Congenital dyserythropoietic anemia type I (CDA-I)Erythrocyte developmental disorders
04

Safety considerations

Essential gene; knockout is embryonic lethal in mice, suggesting complete inhibition may not be tolerated

Beyond the preview

Go deeper on CDAN1-interacting nuclease 1 (CDIN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDAN1-interacting nuclease 1 (CDIN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call